Koji Ishida
Directeur/Bestuurslid bij Sumitomo Pharma America, Inc.
Actieve functies van Koji Ishida
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Directeur/Bestuurslid | - | - |
Loopbaan van Koji Ishida
Eerdere bekende functies van Koji Ishida
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BANK OF JAPAN | Directeur/Bestuurslid | 30-06-2011 | 29-06-2016 |
| SUMITOMO CORPORATION | Directeur/Bestuurslid | 01-06-2017 | - |
| Independent Dir/Board Member | 01-06-2017 | - |
Opleiding van Koji Ishida
| Graduate School of Economics University of Tokyo | Undergraduate Degree |
Statistieken
Internationaal
| Japan | 4 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Government | 2 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BANK OF JAPAN | Government |
| SUMITOMO CORPORATION | Distribution Services |
| Bedrijven in privébezit | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Beurs
- Insiders
- Koji Ishida
- Ervaring
